Online citations, reference lists, and bibliographies.
← Back to Search

Solid Lipid Nanoparticles For Delivery Of Calendula Officinalis Extract.

L. Arana, C. Salado, S. Vega, O. Aizpurua-Olaizola, I. de la Arada, T. Suarez, A. Usobiaga, J. L. R. Arrondo, A. Alonso, F. Goñi, I. Alkorta
Published 2015 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Solid lipid nanoparticles (SLN) composed of long-chain fatty acids (palmitic acid, stearic acid or arachidic acid), Epikuron 200 (purified phosphatidylcholine), and bile salts (cholate, taurocholate or taurodeoxycholate) have been prepared by dilution of a microemulsion. A total of five different systems were prepared, and characterized by photon correlation spectroscopy, transmission electron microscopy, differential scanning calorimetry, and infrared spectroscopy. The SLN formulation showing optimal properties (lowest size and polydispersity index and highest zeta potential) was obtained with stearic acid and taurodeoxycholate as cosurfactant. This formulation was loaded with Calendula officinalis extract, a natural compound used on ophthalmic formulations given its anti-inflammatory, emollient, and wound repairing activity. Calendula-loaded SLN preparations were characterized in order to determine loading capacity and entrapment efficiency. In vitro cytotoxicity and wound healing efficacy of Calendula-loaded SLN compared to that of a free plant extract were evaluated on a conjunctival epithelium cell line WKD. Our results suggest that this SLN formulation is a safe and solvent-free Calendula extract delivery system which could provide a controlled therapeutic alternative for reducing disease-related symptoms and improving epithelium repair in ocular surface.
This paper references
10.1016/J.IJPHARM.2007.07.012
Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
H. Yuan (2008)
10.3109/10611869609015973
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.
R. Mueller (1996)
10.1016/J.ADDR.2007.04.011
Solid lipid nanoparticles for targeted brain drug delivery.
P. Blasi (2007)
10.1016/S0169-409X(00)00122-8
Nanoparticulate systems for brain delivery of drugs.
J. Kreuter (2001)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/j.ijpharm.2007.12.007
Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct.
A. Attama (2008)
10.1016/S0378-5173(00)00471-3
Scale-up of the preparation process of solid lipid nanospheres. Part I.
E. Marengo (2000)
10.1016/0304-4157(84)90017-0
Polymorphic phase behaviour of phospholipid membranes studied by infrared spectroscopy.
H. L. Casal (1984)
10.1016/S0939-6411(97)00107-0
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.
S. Morel (1998)
10.1016/J.EJPB.2005.03.006
Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.
M. Schubert (2005)
10.1016/S0378-5173(02)00080-7
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.
R. Cavalli (2002)
10.3109/10837450.2013.836218
In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate
F. Hashem (2014)
10.1016/j.addr.2011.05.017
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.
S. Cai (2011)
10.1016/j.ejps.2012.10.022
Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.
J. S. Negi (2013)
10.1016/0022-2836(82)90501-0
Intrinsic protein-lipid interactions. Infrared spectroscopic studies of gramicidin A, bacteriorhodopsin and Ca2+-ATPase in biomembranes and reconstituted systems.
M. Cortijo (1982)
10.1111/j.1749-6632.1958.tb36855.x
ORGANIZATION OF RED CELL GLYCOLYTIC ENZYMES: CELL COAT PHOSPHORUS TRANSFER *
G. R. Bartlett (1958)
10.1016/S0031-9422(96)00343-3
Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects.
T. Akihisa (1996)
10.1080/02713680903017500
Sustained Release and Permeation of Timolol from Surface-Modified Solid Lipid Nanoparticles through Bioengineered Human Cornea
A. Attama (2009)
10.4155/TDE.10.22
Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.
H. Sarin (2010)
10.1016/j.fct.2009.02.016
Application of the threshold of toxicological concern approach for the safety evaluation of calendula flower (Calendula officinalis) petals and extracts used in cosmetic and personal care products.
T. A. Re (2009)
10.1016/J.EJPB.2004.03.026
Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.
L. Serpe (2004)
10.1007/978-1-4899-2905-1
The Lipid handbook
F. Gunstone (1994)
10.1016/j.colsurfb.2014.05.026
Bio-active nanoemulsions enriched with gold nanoparticle, marigold extracts and lipoic acid: In vitro investigations.
E. Guler (2014)
10.1016/j.colsurfb.2014.02.041
D-Glucose as a modifying agent in gelatin/collagen matrix and reservoir nanoparticles for Calendula officinalis delivery.
P-L Lam (2014)
10.1002/PCA.772
Supercritical carbon dioxide extraction of marigold at high pressures: comparison of analytical and pilot-scale extraction.
D. Baumann (2004)
10.1155/2012/375671
Wound Healing and Anti-Inflammatory Effect in Animal Models of Calendula officinalis L. Growing in Brazil
L. L. Parente (2012)
10.1016/S0009-3084(98)00080-2
Infrared studies of protein-induced perturbation of lipids in lipoproteins and membranes.
J. L. Arrondo (1998)
10.1016/S0378-8741(97)00061-5
Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.).
K. Zitterl-Eglseer (1997)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1016/j.colsurfb.2009.03.032
Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of beta-carotene and alpha-tocopherol.
S. Trombino (2009)
10.1016/S0378-5173(99)00066-6
Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins
R. Cavalli (1999)
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
B. Siekmann (1996)



This paper is referenced by
10.3390/nano9030464
Solid Lipid Nanoparticles Surface Modification Modulates Cell Internalization and Improves Chemotoxic Treatment in an Oral Carcinoma Cell Line
L. Arana (2019)
10.1016/j.jep.2016.06.002
Medicinal plants used for ophthalmological problems in Navarra (Spain).
M. I. Calvo (2016)
10.3390/jcm8091464
Solid Lipid Nanoparticles Loaded with Glucocorticoids Protect Auditory Cells from Cisplatin-Induced Ototoxicity
Blanca Cervantes (2019)
10.1016/j.ijpharm.2016.12.026
Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor.
S. Makled (2017)
10.1080/17425247.2016.1201059
Application of lipid nanoparticles to ocular drug delivery
L. Battaglia (2016)
10.5772/65652
Natural Compounds for Wound Healing
M. Georgescu (2016)
10.1016/j.ejps.2020.105356
Healing of dermal wounds property of Caryocar brasiliense oil loaded polymeric lipid-core nanocapsules: formulation and in vivo evaluation.
Jader Pires (2020)
10.1007/s13197-018-3316-6
Nanoencapsulation of carotenoids: a focus on different delivery systems and evaluation parameters
Priscilla Pereira dos Santos (2018)
10.12737/23420
Prospects of phytopreparations based on Calendula officinalisin complex treatment of chemical burn of the esophagus
Доржиев (2016)
10.1007/978-3-030-41464-1
Functional Bionanomaterials: From Biomolecules to Nanoparticles
D. Thangadurai (2020)
10.1016/J.JDDST.2017.04.003
Influence of state and crystallinity of lipid matrix on physicochemical properties and permeation of capsaicin-loaded lipid nanoparticles for topical delivery
Veerawat Teeranachaideekul (2017)
10.2174/0929867326666190614123835
Lipid Nanoparticles And Active Natural Compounds: A Perfect Wedding For Pharmaceutical Applications.
C. Puglia (2019)
10.4018/978-1-7998-1518-1.ch006
Optimizing the Size of Drug-Loaded Nanoparticles Using Design of Experiments: Solid Lipid Nanoparticles
Paola Cervantes-Covarrubias (2020)
10.3390/nano9030474
Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
Laura Bayón-Cordero (2019)
10.1016/j.fct.2020.111433
Nanosystems of plant-based pigments and its relationship with oxidative stress.
J. A. Aguirre-Joya (2020)
10.2147/IJN.S174072
Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems
Marziyeh Hajialyani (2018)
10.1080/03639045.2017.1310223
Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer
Zahra Bakhtiary (2017)
10.1007/978-3-030-41464-1_5
Phytonanotechnology for Enhanced Wound Healing Activity
P. Monika (2020)
10.1080/03639045.2019.1620270
Nanocarrier-based systems for wound healing
S. Bernal-Chávez (2019)
10.1016/j.ejps.2018.09.001
Novel chitosan‐based solid‐lipid nanoparticles to enhance the bio‐residence of the miraculous phytochemical “Apocynin”
Reham Mokhtar Aman (2018)
10.1080/03639045.2019.1569027
Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies
Mohana Lakshmi Sabapathi (2019)
10.1016/J.JDDST.2018.05.017
Formulation, characterization and cytotoxicity evaluation of ketotifen-loaded nanostructured lipid carriers
J. E. N. Dolatabadi (2018)
10.1016/j.ejpb.2016.10.006
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
P. Chetoni (2016)
10.1039/C6RA12016D
Ivy leaves extract based – lipid nanocarriers and their bioefficacy on antioxidant and antitumor activities
I. Lăcătuşu (2016)
10.12968/jowc.2018.27.Sup6.S4
The healing properties of medicinal plants used in the Brazilian public health system: a systematic review.
Diorge Jônatas Marmitt (2018)
10.1016/j.msec.2016.05.119
Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies.
M. Geszke-Moritz (2016)
Semantic Scholar Logo Some data provided by SemanticScholar